CAMK2G and obesity disorder: A study based on insulin resistance reported that CaMKII phosphorylates and blocks nuclear translocation of hepatocyte HDAC4 under conditions of obesity: lower nuclear HDAC4 decreases the SUMOylation and degradation of the co-repressor DACH1, and finally, causes defective insulin signaling [37].